FDX1 and nonpapillary renal cell carcinoma: Chen et al. and Zhang et al. reported that higher expression of FDX1 was associated with a better prognosis of renal clear cell carcinoma and could be used as a potential prognostic indicator and therapeutic target for ccRCC [53, 54].